|Bid||26.07 x 800|
|Ask||26.14 x 900|
|Day's Range||24.69 - 27.27|
|52 Week Range||15.58 - 68.65|
|Beta (5Y Monthly)||1.14|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for CSTL
Castle Biosciences, Inc. ( NASDAQ:CSTL ) shareholders will have a reason to smile today, with the analysts making...
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 89.66% and 22.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lumos (LUMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.